Growth Metrics

Palisade Bio (PALI) Free Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 24.91%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.71%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.65%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 31.42%
10 Palisade Bio 439.25 Mn 309.68 Mn - -3.33%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3.33%
Dec 31, 2025 1.76%
Sep 30, 2025 -5.34%
Jun 30, 2025 17.62%
Mar 31, 2025 14.74%
Dec 31, 2024 7.97%
Sep 30, 2024 -4.49%
Jun 30, 2024 23.19%
Mar 31, 2024 -36.51%
Dec 31, 2023 -21.03%
Sep 30, 2023 -45.29%
Jun 30, 2023 -48.36%
Mar 31, 2023 -28.09%
Dec 31, 2022 -17.41%
Sep 30, 2022 -17.02%
Jun 30, 2022 -25.51%
Mar 31, 2022 -31.22%
Dec 31, 2021 -22.60%
Sep 30, 2021 -18.17%
Jun 30, 2021 -45.18%
Mar 31, 2021 12.20%
Dec 31, 2020 12.17%
Sep 30, 2020 36.08%
Jun 30, 2020 41.55%
Mar 31, 2020 27.68%
Dec 31, 2019 20.52%
Sep 30, 2019 24.88%
Jun 30, 2019 23.39%
Mar 31, 2019 21.94%
Dec 31, 2018 25.11%
Sep 30, 2018 33.03%
Jun 30, 2018 19.76%
Mar 31, 2018 26.94%
Dec 31, 2017 13.36%
Sep 30, 2017 -2.04%
Jun 30, 2017 -11.29%
Mar 31, 2017 -16.25%
Dec 31, 2016 -18.02%
Sep 30, 2016 -23.83%
Jun 30, 2016 -2.81%
Mar 31, 2016 -11.69%
Dec 31, 2015 -16.02%
Sep 30, 2015 -57.40%
Jun 30, 2015 -25.55%
Mar 31, 2015 -31.12%
Dec 31, 2014 -25.19%
Sep 30, 2014 -19.81%
Jun 30, 2014 -1.44%
Mar 31, 2014 -6.49%
Dec 31, 2013 3.91%
Sep 30, 2013 -0.03%